Similarly, IGF2BP2, KIAA1429, METTL16, METTL3, and YTHDF1 also exhibited a consistent upregulation at both mRNA and protein levels in five GBM datasets (2.15E-19 < FDR < 4.43E-09) (Figures 2A,C,D and Supplementary Table S3). The gene discussed is IGF2BP2; the disease is glioblastoma.